News

The new vaccine will be manufactured at a newly-established facility at the company’s Hikari Plant in Hikari City, Yamaguchi Prefecture. In 2010, Takeda and Baxter International have entered

Alprolix is indicated for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with haemophilia B. The company said that

Lipoparticles are an enabling technology for the company’s MPS Discovery Engine for isolating monoclonal antibodies (MAbs) against membrane protein targets. Lipoparticles are used to generate conformationally-sensitive, inhibitory MAbs

The Letter Of Intent was signed with another public company listed on the OTCQB exchange. Easton has engaged an attorney who for the past few days and moving

The transaction, which is with three connected entities, also includes GSK divesting a non-core brand and a manufacturing facility in the country. GSK has also divested its Insto

Through these enhancements, Caris Molecular Intelligence will now provide oncologists even more potentially useful treatment information for some of the most challenging cancers, including ovarian, head and neck,

Pergoveris is a combination of recombinant human follicle stimulating hormone (r-hFSH) and recombinant human luteinizing hormone (r-hLH) delivered through subcutaneous injection. The multi-center, randomized, controlled, single-blind, parallel Espart

The approval marks a major step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years. Pfizer acquired

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) had already issued a positive opinion for Latuda in January 2014. Latuda is an atypical